Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

BST2 protein and certain T cells increase in early alopecia areata.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Non-drug therapies show promise for hair regrowth but need more research.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Natural products show promise for new hair loss treatments.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The review concluded that keeping the hair-growing ability of human dermal papilla cells is key for hair development and growth.

Cattle skin has leptin which might control skin and hair growth.

New therapies for alopecia areata show potential but need more research.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Hair and skin healing involve complex cell interactions controlled by specific molecules and pathways, and hair follicle cells can help repair skin wounds.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

PRP treatment may help with alopecia areata, especially in newer cases.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Microneedles could be a better and easier way to regrow hair.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Many men with androgenic alopecia also have dyslipidemia.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.